| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09:18 | Faron Pharmaceuticals launches €40m rights offering | ||
| 09:18 | Norman Broadbent plans capital reduction to create distributable reserves | ||
| 09:18 | B.Riley initiates Strive Enterprises stock with buy rating | ||
| 09:18 | B.Riley initiates Strategy stock coverage with buy rating on Bitcoin holdings | ||
| 09:18 | TD Cowen downgrades Novo Nordisk stock rating on pipeline concerns | ||
| 09:18 | Roth/MKM initiates NeuroSense stock with buy on ALS drug potential | ||
| 09:18 | Jefferies initiates Life Time stock with buy on premium fitness model | ||
| 08:54 | Abingdon Health shares to begin trading on OTCQB next month | ||
| 08:54 | Nuformix receives FDA orphan drug status for IPF treatment | ||
| 08:54 | Redx Pharma's RXC008 gets FDA fast track for Crohn's disease | ||
| 08:54 | KeyBanc upgrades Federal Signal stock rating on growth strategy | ||
| 08:54 | KeyBanc downgrades Talkspace stock rating on UHS acquisition | ||
| 08:42 | Videndum secures £85m equity raise in comprehensive refinancing | ||
| 08:42 | Astrid Intelligence acquires Bittensor network validator | ||
| 08:42 | Technology Minerals' Recyclus launches crowdfunding campaign | ||
| 08:42 | Catenai investee Alludium launches AI agent platform | ||
| 08:42 | RBC Capital downgrades Beiersdorf stock rating on Nivea challenges | ||
| 08:18 | James Cropper partners with Hexcel on recycled carbon fiber | ||
| 08:18 | Ondine Biomedical reports 93% enrollment in Phase 3 infection study | ||
| 08:18 | Costain launches £20m share buyback program | ||
| 07:18 | BaFin launches audit of Gerresheimer's interim financial statements | ||
| 02:54 | Yalla Q4 2025 slides: margins surge to 41% despite revenue dip | ||
| 02:30 | Calidi Biotherapeutics closes $6M public offering | ||
| 01:42 | HPE Q1 FY26 slides: networking surges 152%, AI backlog tops $5B | ||
| 01:18 | Twin Vee PowerCats withdraws proposed stock offering |